• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23488 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2000     Alberta Heritage Foundation for Medical Research (AHFMR) A technology index of hospital expenditure growth in Canada (HEAT 4). (Fourth in a series on the Health Expenditure and Technology project, jointly with the Institute of Health Economics)
2000     Hannover Medical School, Medizinische Hochschule Hannover (MHH) PSA screening for prostate carcinoma
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Overview of the project (HEAT 5). (Fifth in a series on the Health Expenditure and Technology project, jointly with the Institute of Health Economics)
2000     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Positron emission tomography - the economic efficacy
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne (TM) therapy for the treatment of age-related macular degeneration
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Chemoembolization treatment for colorectal metastases to the liver
2000     HAYES, Inc. Intracoronary radiation therapy
2000     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and treatment of uncomplicated acute sinusitis in children
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of ultrasound-assisted lipoplasty (update and re-appraisal)
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Comparison of two methods on the speech audiogram and the Nal-r-method based on calculations making use of the pure tone audiogram - primary research
2000     Agency for Healthcare Research and Quality (AHRQ) Determinants of disability in patients with chronic renal failure
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of lung volume reduction surgery (update and re-appraisal)
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Electric stimulation in post-traumatic dystrophy - primary research
2000     HAYES, Inc. Intravenous immunoglobulin for hematological diseases
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [HTA, health services research, and clinical practice. Report from a symposium in evidence based health care]
2000     Agency for Healthcare Research and Quality (AHRQ) Management of chronic hypertension during pregnancy
2000     Basque Office for Health Technology Assessment (OSTEBA) [Health centre major surgery in Osakidetza - Basque Health Service]
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Evaluation of the combination day- and home treatment of psoriasis - primary research
2000     HAYES, Inc. Intravenous immunoglobulin for neurological diseases
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Intracoronary flow measurement versus scintigraphic exercise monitoring for determining the therapeutic policy for narrowing of the intermediary coronary artery - primary research
2000     HAYES, Inc. Intravenous immunoglobulin for pediatric AIDS
2000     Agency for Healthcare Research and Quality (AHRQ) Management of preterm labour. Volume 1: Evidence report and appendixes; Volume 2: Evidence tables
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Irradiation and surgery of Graves' ophthalmopathy - primary research
2000     HAYES, Inc. Intravenous immunoglobulin for pulmonary diseases
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of minimally invasive techniques for the relief of bladder outflow obstruction (update and re-appraisal)
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Radio-frequency (thermo) lesions in lumbosacral spinal column - primary research
2000     HAYES, Inc. Intravenous immunoglobulin for rheumatic diseases
2000     Health Council of the Netherlands Gezondheidsraad (GR) Exposure to elecromagnetic fields
2000     Agency for Healthcare Research and Quality (AHRQ) Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Health registers - how, why and for whom?
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) The effect of peripherally isolated stem cells on haematological recovery from high-dose chemotherapy in patients with Hodgkin or non-Hodgkin lymphoma - primary research
2000     Health Council of the Netherlands Gezondheidsraad (GR) Intensive care at birth
2000     Agency for Healthcare Research and Quality (AHRQ) Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of neck complaints - primary research
2000     Health Council of the Netherlands Gezondheidsraad (GR) Exposure to radon (Evaluation of the BEIR VI report)
2000     Agency for Healthcare Research and Quality (AHRQ) Prevention of venous thromboembolism after injury
2000     Institute for Clinical Evaluative Sciences (ICES) An examination of how hospitals use the reporting framework prescribed in the Ontario Hospital Reporting System
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of suppurative otitis media in young children - primary research
2000     Medical Services Advisory Committee (MSAC) Hyperbaric oxygen therapy
2000     Health Council of the Netherlands Gezondheidsraad (GR) Leukodepletion of blood products (New variant Creutzfeldt-Jakob disease and leukodepletion)
2000     Agency for Healthcare Research and Quality (AHRQ) Criteria for weaning from mechanical ventilation
2000     Health Council of the Netherlands Gezondheidsraad (GR) Medical fitness-to-drive of persons with an implantable cardioverter defibrillator (ICD)
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) The patient in the data network - advantages and risks of computer-based patient records. Short version of the TA-study 'Computer-based patient records'
2000     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination policies in case of an influenza pandemic
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Between the pantry and the pharmacy: functional food - a grey area. Short version of the TA-study 'functional food'.
2000     Medical Services Advisory Committee (MSAC) Sacral nerve stimulation for refractory urinary urge incontinence or urinary retention
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2000     Medical Services Advisory Committee (MSAC) Funding for new medical technologies and procedures: application and assessment guidelines
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Antiretroviral therapy for HIV infection in patients naive to prior treatment: a systematic review of effectiveness and cost-effectiveness
2000     University HealthSystem Consortium (UHC) Antidiabetic agents
2000     Agency for Healthcare Research and Quality (AHRQ) Small bowel transplantation
2000     University HealthSystem Consortium (UHC) Thrombolytics for MI
2000     University HealthSystem Consortium (UHC) Etanercept
2000     HAYES, Inc. Lipoprotein analysis for the diagnosis and management of dyslipidemia
2000     ECRI Implantable sacral nerve stimulation for the treatment of idiopathic urinary dysfunction
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of endovascular coil treatment of intracranial aneurysms]
2000     University HealthSystem Consortium (UHC) COX-2
2000     HAYES, Inc. Lipoprotein(a) enzyme immunoassay for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000     New Zealand Health Technology Assessment (NZHTA) Annotated bibliography: direct access echocardiography and exercise ECG testing
2000     NIHR Health Technology Assessment programme Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Osteoarthritis treatment with Hyalgan - an HTA
2000     University HealthSystem Consortium (UHC) Bisphosphonates
2000     HAYES, Inc. Lithotripsy for pancreatic stones and gallstones
2000     TNO Feasibility study: an information system to support purchasing of medical devices and services within healthcare organizations
2000     NIHR Health Technology Assessment programme Community provision of hearing aids and related audiology services
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Triple test for all pregnant women? A health technology assessment]
2000     University HealthSystem Consortium (UHC) Aspirin 25mg/extended release dipyridamole 200mg
2000     HAYES, Inc. Lithotripsy for salivary stones
2000     TNO Guidelines for the organization and monitoring of diabetes self-regulation in the Netherlands
2000     NIHR Health Technology Assessment programme False-negative results in screening programmes: systematic review of impact and implications
2000     University HealthSystem Consortium (UHC) Varicella-zoster
2000     TNO Evaluation of transfer offices; report from baseline measurement
2000     NIHR Health Technology Assessment programme Costs and benefits of community postnatal support workers: a randomised controlled trial
2000     Agency for Healthcare Research and Quality (AHRQ) Intestinal and multivisceral (small bowel) transplantation - systematic review
2000     University HealthSystem Consortium (UHC) Dofetilide
2000     ECRI Intestine and intestine-liver transplantation : update
2000     TNO Evaluation of three transmural care models; a compilation of four concept articles from the project: tertiary prevention of chronic illness in transmural care
2000     NIHR Health Technology Assessment programme An introduction to statistical methods for health technology assessment: a review
2000     University HealthSystem Consortium (UHC) Rosiglitazone
2000     University HealthSystem Consortium (UHC) LMW heparins revised
2000     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Hip replacement with osteoarthritis]
2000     University HealthSystem Consortium (UHC) Ribavirin/interferon alfa 2b
2000     Basque Office for Health Technology Assessment (OSTEBA) [New imaging techniques for diagnosis of breast cancer: digital mammography, impedance and electrical conductivity]
2000     University HealthSystem Consortium (UHC) Inhaled corticosteroids for asthma
2000     Basque Office for Health Technology Assessment (OSTEBA) [Auditive implants: concept, indications and appropriate use]
2000     University HealthSystem Consortium (UHC) Mecasermin
2000     Basque Office for Health Technology Assessment (OSTEBA) [Human assisted reproductive techniques: Description of the available therapeutic options]
2000     Health Services Utilization and Research Commission (HSURC) The impact of preventive home care and seniors housing on health outcomes
2000     University HealthSystem Consortium (UHC) Levalbuterol
2000     HAYES, Inc. Low density lipoprotein subclass testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000     NIHR Health Technology Assessment programme A systematic review to evaluate the effectiveness of interventions to promote the initation of breastfeeding
2000     University HealthSystem Consortium (UHC) Anti-influenza agents
2000     NIHR Health Technology Assessment programme Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review
2000     University HealthSystem Consortium (UHC) Palivizumab
2000     NIHR Health Technology Assessment programme A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies
2000     University HealthSystem Consortium (UHC) Linezolid
2000     ECRI (111)In-capromab pendetide for staging prostate cancer in men at high risk of metastasis
2000     NIHR Health Technology Assessment programme Intravascular ultrasound-guided interventions in coronary artery disease: a systematic literature review, with decision-analytic modelling, of outcomes and cost-effectiveness
2000     University HealthSystem Consortium (UHC) Neuromuscular blocking agents update
2000     NIHR Health Technology Assessment programme A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression